These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 32943195)

  • 1. Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy.
    Selvakumar D; Clayton ZE; Chong JJH
    Clin Ther; 2020 Oct; 42(10):1857-1879. PubMed ID: 32943195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?
    Selvakumar D; Reyes L; Chong JJH
    Curr Cardiol Rep; 2022 May; 24(5):445-461. PubMed ID: 35275365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
    Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
    Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
    [No Abstract]   [Full Text] [Related]  

  • 5. Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.
    Oikonomopoulos A; Kitani T; Wu JC
    Mol Ther; 2018 Jul; 26(7):1624-1634. PubMed ID: 29699941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E
    Fang YH; Wang SPH; Liao IC; Tsai KJ; Huang PH; Yang PJ; Yen CJ; Liu PY; Shan YS; Liu YW
    Adv Healthc Mater; 2023 Nov; 12(29):e2301186. PubMed ID: 37672681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions.
    Garbern JC; Escalante GO; Lee RT
    Trends Cardiovasc Med; 2021 Feb; 31(2):85-90. PubMed ID: 31983535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac stem cell therapy: review of the native cardiac progenitor cells and future direction.
    Ye J; Yeghiazarians Y
    J Cardiovasc Pharmacol; 2014 Feb; 63(2):85-94. PubMed ID: 23674056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes.
    Ge F; Wang Z; Xi JJ
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells.
    Bel A; Planat-Bernard V; Saito A; Bonnevie L; Bellamy V; Sabbah L; Bellabas L; Brinon B; Vanneaux V; Pradeau P; Peyrard S; Larghero J; Pouly J; Binder P; Garcia S; Shimizu T; Sawa Y; Okano T; Bruneval P; Desnos M; Hagège AA; Casteilla L; Pucéat M; Menasché P
    Circulation; 2010 Sep; 122(11 Suppl):S118-23. PubMed ID: 20837902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart.
    Higuchi T; Miyagawa S; Pearson JT; Fukushima S; Saito A; Tsuchimochi H; Sonobe T; Fujii Y; Yagi N; Astolfo A; Shirai M; Sawa Y
    Cell Transplant; 2015; 24(12):2479-89. PubMed ID: 25606821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise Review: Reduction of Adverse Cardiac Scarring Facilitates Pluripotent Stem Cell-Based Therapy for Myocardial Infarction.
    Liang J; Huang W; Jiang L; Paul C; Li X; Wang Y
    Stem Cells; 2019 Jul; 37(7):844-854. PubMed ID: 30913336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
    Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF
    Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias.
    Romagnuolo R; Masoudpour H; Porta-Sánchez A; Qiang B; Barry J; Laskary A; Qi X; Massé S; Magtibay K; Kawajiri H; Wu J; Valdman Sadikov T; Rothberg J; Panchalingam KM; Titus E; Li RK; Zandstra PW; Wright GA; Nanthakumar K; Ghugre NR; Keller G; Laflamme MA
    Stem Cell Reports; 2019 May; 12(5):967-981. PubMed ID: 31056479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent conjugated polymer nanovector for in vivo tracking and regulating the fate of stem cells for restoring infarcted myocardium.
    Jin G; Li W; Song F; Zhao J; Wang M; Liu Q; Li A; Huang G; Xu F
    Acta Biomater; 2020 Jun; 109():195-207. PubMed ID: 32294553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiogenic differentiation and transdifferentiation of progenitor cells.
    Reinecke H; Minami E; Zhu WZ; Laflamme MA
    Circ Res; 2008 Nov; 103(10):1058-71. PubMed ID: 18988903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
    Duelen R; Sampaolesi M
    EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and Challenge of Cardiac Regeneration to Treat Heart Failure.
    Isomi M; Sadahiro T; Ieda M
    J Cardiol; 2019 Feb; 73(2):97-101. PubMed ID: 30420106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.